Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2022, 31(2):89-93

Comment on 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Lesný P, Gonçalvesová E
Kardiologická klinika LFUK a NÚSCH, a. s., Bratislava, Slovenská republika

Published: February 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lesný P, Gonçalvesová E. Comment on 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Cardiology Letters. 2022;31(2):89-93.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;00:1-128. Go to original source...
    2. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016;18:891-975. Go to original source...
    3. Goncalvesová E, Lesný P, Luknár M, et al. Komentar k Odporúčaniam ESC pre diagnostiku a liečbu akútneho a chronického srdcového zlyhávania. Cardiology Lett. 2017;26:221-222.
    4. Vaduganathan M, Claggett BL, Jhund PS, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fracton: a comparative analysis of three randomised controlled trials. Lancet. 2020;396:121-128. Go to original source...
    5. Rosano GMC, Moura B, Metra M, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021;23:872-881. Go to original source...
    6. McMurray JJV, Packer M. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction ?: A Redefinition of Evidence-Based Medicine. Circulation. 2021;143:875-877. Go to original source...
    7. Maddox TM, Januzzi JL, Allen LA, et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021;77:772-810. Go to original source...
    8. Kober L, Thune JJ, Nielsen JC, et al. Defibrillator Implantation in Patients with nonischemic Systolic Heart Failure. N Engl J Med. 2016;375:1221-1230. Go to original source...
    9. Rohde LE, Chatterjee NA, Vaduganathan M, et al. Sacubitril/ Valsartan and Sudden Cardiac Death According to Implantable CardioverterDefibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis. JACC Heart Fail. 2020;8:844-855. Go to original source...
    10. Curtain JP, Docherty KF, Jhund PS, et al. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. Eur Heart J. 2021;42:3727-3738. Go to original source...
    11. Woods B, Hawkins N, Mealing S, et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart. 2015;101:1800-1806. Go to original source...
    12. Lewis GD, Malhotra R, Hernandez AF, et al. NHLBI Heart Failure Clinical Research Network. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA 2017;317:1958-1966. Go to original source...
    13. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451-1461. Go to original source...
    14. European Commission. Union Register of medicinal products for human use. Available at: https://ec.europa.eu/health/documents/community-register/html/h930.htm. Last accessed: March 2022.
    15. Lesný P, Hulman M, Olejárová I, et al. Dlhodobé mechanické podpory ľavej komory v liečbe srdcového zlyhávania na Slovensku. Cardiology Lett. 2020;29:50-56.
    16. Nitsche C, Aschauer S, Kammerlander AA, et al. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 2020;22:1852-1862. Go to original source...
    17. Danková M, Goncalvesová E. Amyloidová kardiomyopatia - zriedkavá alebo neodhalená? Cardiology Lett. 2020;29:17-25. Go to original source...

    Return to the content